Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664

Mechanism of activation of protein kinase B by insulin and IGF‐1.

Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014

Cellular mechanisms of insulin resistance

Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714

Molecular mediators of hepatic steatosis and liver injury

Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772

Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle

Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease

Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322

Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis

Cases, S., Smith, S. J., Zheng, Y.-W., Myers, H. M., Lear, S. R., Sande, E., Novak, S., Collins, C. C., Welch, C. L., Lusis, A. J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13018 · Cited by 1,138

Enzymes of triacylglycerol synthesis and their regulation

Coleman, R. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00051-1 · Cited by 985

Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes

Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911

Transcriptomic and epigenomic signatures of liver metabolism and insulin sensitivity in aging mice

González, J. T., Scharfman, O. H., Zhu, W., Kasamoto, J., Gould, V., Perry, R. J., & Higgins‐Chen, A. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112068 · Cited by 6

Ancestral bisphenol A exposure led to non-alcoholic fatty liver disease and sex-specific alterations in proline and bile metabolism pathways in the liver

Chakraborty, S., Anand, S., Numan, M., & Bhandari, R. K. (2025) · Environmental Toxicology and Chemistry · doi:10.1093/etojnl/vgae081 · Cited by 6

A novel regulatory facet for hypertriglyceridemia: The role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis

Khalifeh, M., Santos, R. D., Oskuee, R. K., Badiee, A., Aghaee‐Bakhtiari, S. H., & Sahebkar, A. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101197 · Cited by 6

Methionine-Mediated Regulation of Intestinal Lipid Transportation Induced by High-Fat Diet in Rice Field Eel (Monopterus Albus)

Hu, Y., Zhang, J., Cai, M., Chu, W., & Hu, Y. (2023) · Aquaculture Nutrition · doi:10.1155/2023/5533414 · Cited by 8

Omega‐3 Fatty Acid–Rich Parenteral Nutrition

Kyrana, E., & Dhawan, A. K. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000863 · Cited by 6

Lipid droplets in the immune response and beyond

Gandotra, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00010-5 · Cited by 5

Methionine-Mediated Regulation of Intestinal Structure and Lipid Transport in the Rice Field Eel (Monopterus albus)

Hu, Y., Cai, M., Zhong, H., Chu, W., & Hu, Y. (2022) · Aquaculture Nutrition · doi:10.1155/2022/2293484 · Cited by 6

Dual targeting of hepatocyte DGAT2 and stellate cell FASN alleviates nonalcoholic steatohepatitis in micePreprint

Yenilmez, B., Harney, S. M., DiMarzio, C., Kelly, M., Min, K., Echeverria, D., Bramato, B. M., Jackson, S. O., Reddig, K. R., Kim, J. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.05.547848 · Cited by 7

Zebrafish are resilient to the loss of major diacylglycerol acyltransferase enzymes

Wilson, M. H., Hensley, M. R., Shen, M., Lu, H.-Y., Quinlivan, V. H., Busch‐Nentwich, E. M., Rawls, J. F., & Farber, S. A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107973 · Cited by 5

Multiple molecular targets in the liver, adipose tissue and skeletal muscle in ginger-elicited amelioration of nonalcoholic fatty liver disease

Wang, C., Batey, R. G., Yamahara, J., & Li, Y. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.06.040 · Cited by 5

Dietary Macronutrient Composition Determines the Contribution of DGAT 1 to Alcoholic Steatosis

Huang, L., Yuen, J. J., Trites, M. J., Saha, A., Epps, C. T., Hu, Y., Kerolle, S., Lee, S., Jiang, H., Goldberg, I. J., et al. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13881 · Cited by 5

Cholesterol Regulation by Leptin in Alcoholic Liver Disease

Vairappan, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800773-0.00015-x · Cited by 5

Expanding the Scope of the Cleavable N-(Methoxy)oxazolidine Linker for the Synthesis of Oligonucleotide Conjugates

Aho, A., Äärelä, A., Korhonen, H. J., & Virta, P. (2021) · Molecules · doi:10.3390/molecules26020490 · Cited by 7

Hongqu Rice Wines Ameliorate High-Fat/High-Fructose Diet-Induced Metabolic Syndrome in Rats

Zhang, N., Kong, F., Jing, X., Zhou, J., Zhao, L., Soliman, M. M., Zhang, L., & Zhou, F. L. (2022) · Alcohol and Alcoholism · doi:10.1093/alcalc/agac033 · Cited by 4

Drug Targeting of Acyltransferases in the Triacylglyceride and 1-O-AcylCeramide Biosynthetic Pathways

Hernandez‐Corbacho, M. J., & Canals, D. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000763 · Cited by 4

Anti‐hyperlipidaemic effects of synthetic analogues of nordihydroguaiaretic acid in dyslipidaemic rats

Singh, M., Bittner, S., Li, Y., Bittner, A., Han, L., Cortez, Y., Inayathullah, M., Arif, Z., Parthasarathi, R., Rajadas, J., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14528 · Cited by 4

The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer

Mohammed, E. D., Abdel‐Naim, A. B., Jin, K., Jiang, R., Wei, J., & Sun, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118615 · Cited by 4

Histopathological and biochemical studies in male Wistar albino rats injected with diethylnitrosamine and treated with Camel’s milk and Curcuma longa

Alhomaid, F. A., & Hassan, O. (2016) · Egyptian Journal of Chemistry and Environmental Health · doi:10.21608/ejceh.2016.254619 · Cited by 4

X-box binding protein 1: A new metabolic mediator and drug target of metformin?

Lou, K., Sun, P., Zhang, C., Jiang, Q., & Pang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1013218 · Cited by 3

Advancing metabolic dysfunction associated steatotic liver disease (MASLD) Treatment: Exploring novel formulations and therapies

Barbhuiya, P. A., Ahmed, A., & Pathak, M. P. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107702 · Cited by 3

APOC3 Promotes DGAT2-Dependent Triglyceride Accumulation in Hepatocytes During Early Metabolic Dysfunction

Nguyen, T. N., Kim, H.-J., Shim, H. M., Kang, J., Ha, E. Y., Cho, H., & Park, J. (2026) · Biomolecules · doi:10.3390/biom16040607 · Cited by 3

Treatment of preadipocytes with fish oil, mixed oil, or soybean oil-based lipid emulsions have differential effects on the regulation of lipogenic and lipolytic genes in mature 3T3-L1 adipocytes

Isesele, P., Vaidya, H. B., Gill, R., & Cheema, S. K. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102396 · Cited by 3

Graphislactone A, a Fungal Antioxidant Metabolite, Reduces Lipogenesis and Protects against Diet-Induced Hepatic Steatosis in Mice

Lee, Y., Jang, H.-R., Lee, D., Lee, J., Jung, H.-R., Cho, S., & Lee, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021096 · Cited by 3

Married at Birth: Regulation of Cellular Fat Metabolism by ER–Lipid Droplet Crosstalk

Cao, Z., & Mak, H. Y. (2020) · Contact · doi:10.1177/2515256420934671 · Cited by 6

Paradoxical activation of SREBP1c and de novo lipogenesis by hepatocyte-selective ACLY depletion in obese micePreprint

Yenilmez, B., Kelly, M., Zhang, G., Wetoska, N., Ilkayeva, O., Min, K., Rowland, L. A., DiMarzio, C., He, W., Raymond, N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.21.485183 · Cited by 3

Prebiotic and Probiotic Foods in MASLD: Microbiome-Mediated Therapeutic Strategies

Cui, B., Liu, Y., Joyce, H., Jieying, C., Jia-hang, X., Jian-Peng, T., & Chun, L. H. (2025) · Synthetic biology and engineering · doi:10.70322/sbe.2025.10018 · Cited by 3

Ferroptosis regulation by SGLT2 inhibitors: mechanisms and clinical benefits in diabetic kidney disease

He, S., Wu, Z., & Li, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1808167 · Cited by 2

Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives

Zadeh, S. S. T., Toth, P. P., & Banach, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1789019 · Cited by 2

Molecular mechanisms and pathogenesis of MASH

Gallage, S., Govaere, O., Anstee, Q. M., Shulman, G. I., Tacke, F., & Heikenwälder, M. F. (2026) · Nature · doi:10.1038/s41586-026-10529-0 · Cited by 3

The Postnatal Resolution of Developmental Toxicity Induced by Pharmacological Diacylglycerol Acyltransferase 2 (DGAT2) Inhibition During Gestation in Rats

Catlin, N. R., Bowman, C., Campion, S. N., Lewis, E. M., Nowland, W. S., Stethem, C. M., & Cappon, G. D. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac077 · Cited by 2

Angiotensin II Alters Mitochondrial Membrane Potential and Lipid Metabolism in Rat Colonic Epithelial Cells

Toth, D. D., Souder, C., Patuel, S. J., English, C. D., Konig, I., Ivantsova, E., Malphurs, W., Watkins, J., Costa, K. A., Bowden, J. A., et al. (2024) · Biomolecules · doi:10.3390/biom14080974 · Cited by 2

Garcinia mangostana Suppresses Triacylglycerol Synthesis in Hepatocytes and Enterocytes

Kwon, E., Moon, D., Oh, E. S., Song, Y. N., Park, J., Ryu, H. W., Kim, D.-Y., Chin, Y., Lee, H.-S., Lee, S. U., et al. (2023) · Journal of Medicinal Food · doi:10.1089/jmf.2023.k.0008 · Cited by 2

C5L2 Deficiency Enhances Development of Atherosclerosis in ApoE Knockout Mice

Liu, Y., Fisette, A., Lapointe, M., & Cianflone, K. (2015) · Chinese Medicine · doi:10.4236/cm.2015.61007 · Cited by 1

Enfermedad del hígado graso no alcohólico y riesgo cardiovascular

Hernando, Á. B., & Puzo, J. (2010) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2010.10.004 · Cited by 1

Potential Therapeutic Strategies for Fat Induced Insulin Resistance

Choi, C. S. (2009) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2009.24.2.65 · Cited by 1

DS-7250, a Diacylglycerol Acyltransferase 1 Inhibitor, Enhances Hepatic Steatosis in Zucker Fatty Rats via Upregulation of Fatty Acid Synthesis

Yasuno, K., Kumagai, K., Iguchi, T., Tsuchiya, Y., Kai, K., & Mori, K. (2018) · Toxicologic Pathology · doi:10.1177/0192623318765909 · Cited by 1

Acyl ghrelin, desacyl ghrelin and their ratio affect hepatic steatosis via PPARγ signaling pathway

Elibol, E., Akdevelıoğlu, Y., Yılmaz, C., Narlı, B., Şen, S., Kaplanoğlu, G. T., & Seymen, C. M. (2024) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2023.12.007 · Cited by 1

The association between serum free fatty acid levels and neurological outcomes in out-of-hospital cardiac arrest patients: A prospective observational study

Lee, D. H., Lee, B. K., Jeung, K., & Jung, Y.-H. (2024) · Medicine · doi:10.1097/md.0000000000038772 · Cited by 1

The Progression of Non-alcoholic Fatty Liver Disease and Lifestyle Intervention in Older Adults

Jia, X., Naito, H., Kitamori, K., Yetti, H., & Nakajima, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-418680-4.00009-9 · Cited by 1

Myocardial Oxidative Stress and Metabolic Diseases

El‐Sayyad, H. I. (2019) · Springer eBooks · doi:10.1007/978-981-13-8946-7_4 · Cited by 1

The role of adipose triglyceride lipase in hepatic lipid metabolism, non-alcoholic fatty liver disease and insulin resistance

Ong, K. T. (2013) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1

Présentée DEVANT L'INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE LYON

Docteur, L. G. D., & Zarrouki, B. (2007) · Cited by 1

Therapeutic Approaches for Nonalcoholic Steatohepatitis ( NASH )

Glatthar, R., & Arch, R. H. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc274 · Cited by 1

Evolution of spatial and temporal cis -regulatory divergence between marine and freshwater sticklebacksPreprint

Mack, K. L., Square, T. A., Zhao, B., Miller, C. T., & Fraser, H. B. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.30.510353 · Cited by 1

Efeitos do deidroepiandrosterona (DHEA) sobre a função vascular e a resistência periférica à insulina em um modelo experimental de menopausa.

Camporez, J. P. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2012.tde-25072012-111253

Cinética lipídica en el tratamiento antiviral dual en pacientes con hepatitis crónica C

Jiménez-Macías, F. M., Alor, F. B., Monge, P. G. C., Lora, M. R., de la Llave, E. P., & Ruíz-Frutos, C. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2013.12.016

Metabolic Pathways of Type 2 Diabetes Intersection of Genetics, Transcriptomics, and Metabolite Profiling

Ferrara, C. T. (2008) · DukeSpace (Duke University)

Genetische Mechanismen der Gewichtsregulation: genomweite Ansätze und Kandidatengenstudien

Friedel, S. (2009) · Common Library Network (Der Gemeinsame Bibliotheksverbund)

Characterization Of Mango Peel Mangiferin To Elucidate Its Nutraceutical Potential

Muhammad, I. (2013) · HEC National Digital Library

Role of Lipogenesis and Lipid Desaturases in Non-alcoholic Fatty Liver Disease

Lounis, M. A., Rial, S. A., Ntambi, J. M., & Mounier, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-25065-6_7

Omega‐3 Fatty Acid‐rich Parenteral Nutrition

Ibrahim, S. H. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001091

Glycerol -3 -phosphate acyltransferase isoforms: Hepatic triacylglycerol synthesis and the development of insulin resistance

Nagle, C. A. (2007)

The impact of lifestyle factors on whole-body lipid handling and skeletal muscle mitochondrial content and function

Matravadia, S. (2016) · The Atrium (University of Guelph)

Molecular antagonists, leptin or other hormones in supplementing environmental factors?

Hazlehurst, J., & Tomlinson, J. (2016) · doi:10.1002/9781118924938.ch24

Cholesterol Plays a Crucial Role in High-fat-diet Induced ER stress and Non-alcoholic Fatty Liver Disease

Bashiri, A. (2014) · TSpace (University of Toronto)

Proteomics of lipid accumulation and DGAT inhibition in HepG2 liver carcinoma cells

Bhatt-Wessel, B. (2017) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17058194

In Vivo Role of JAK2 in the Pathogenesis of Obesity and the Metabolic Syndrome

Shi, S. Y. (2015) · TSpace (University of Toronto)

Lipid kinetics during dual antiviral therapy in patients with chronic hepatitis C

Jiménez-Macías, F. M., Alor, F. B., Monge, P. G. C., Lora, M. R., de la Llave, E. P., & Ruíz-Frutos, C. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.12.031

The lipidomics of non-alcoholic fatty liver disease : from in vitro to human studies

Peng, K. (2017) · Minerva Access (University of Melbourne)

Yeast FIT2 homologs mediate the crosstalk between stress response pathways and cellular proteostasis

Teng, P. S. J. (2019) · doi:10.32657/10220/47624

An exploration into the proteins that regulate skeletal muscle lipid metabolism

Whytock, K. L. (2021) · Liverpool John Moores University · doi:10.24377/ljmu.t.00009962

Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training

Jolin-Rodrigue, G. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-23150

Insulin sensitivity is mediated by glucose in the hepatoportal region in the rat

Johnson, H. M. (2017) · The Sydney eScholarship Repository (The University of Sydney)

Investigating the effects of carbohydrate or fatty acid treatment on lipid content in HepG2 human hepatocytes & mouse primary hepatocytes

Clarke, M. J. (2013) · Surrey Research Insight Open Access (The University of Surrey)

Current World Literature

(2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328303e27e

Uncoupling of fat deposition and inflammation during nonalcoholic fatty liver disease

Li, H., Guo, X., Aquino, E., & Wu, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95582-9.00012-7

Application of Framework Nucleic Acid‐Based Nanomaterials in the Treatment of Endocrine and Metabolic Diseases

Xiao, J. (2024) · Wiley eBooks · doi:10.1002/9783527841912.ch8

Nonalcoholic fatty liver disease is a risk factor for cardiovascular disease

Li, Q. I. N., JunRu, W. U., YuQing, L. I. U., YingXuan, G. O. N. G., & JingJing, C. A. I. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2024-0098

Impaired hepatic metabolism in Hereditary Fructose Intolerance confers fructose-independent risk for steatosis and hypertriglyceridemia

Fulham, M. A., Griffin, J. D., Perez, S., Sun, Z., Daurio, N. A., Xing, G., Clasquin, M. F., Miller, M. R., Hyde, C. L., Kelly, S. P., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102310

Additional file 1 of Gut microbiome and metabolism alterations in schizophrenia with metabolic syndrome severity

Zhao, H., Zhu, G., Zhu, T., Ding, B., Xu, A., Gao, S., Chao, Y., Li, N., Chen, Y., Wang, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753221

Advances in Biotechnology for Diabetes Research and Therapy

Nandakumar, M., Darwish, R., Butler, A. E., & Moin, A. S. M. (2026) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-3612-2_9

Inflammation promotes hepatic but not adipose tissue DGAT2 expression and triglyceride synthesis in MAFLD mice

Vairappan, B., Chandrasekar, A., & Ravikumar, T. S. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156439

Ontogenetic expression of bile and lipid metabolism genes in Atlantic cod (Gadus morhua L.) larvae in relation to hepatic lipid accumulation

Marthinsen, J. L., Kjørsvik, E., Whatmore, P., Li, K., Steineke, M. L., & Olsen, R. E. (2026) · Frontiers in Marine Science · doi:10.3389/fmars.2026.1791338

Implication of mitochondria endoplasmic-reticulum interactions in the control of hepatic metabolism

Theurey, P. (2015) · theses.fr (ABES) · doi:10.70675/c827066dz5c76z4f0azb465z409dc90bb0e5

Mécanisme de l'insulino-résistance lors de la modulation in vivo et in vitro par l'acide nicotinique et les polyphénols

Blond, E. (2012) · theses.fr (ABES) · doi:10.70675/189ac795z9e7az4eb1z9b88z991750b0b668

Homéostasie des céramides et hépatopathies métaboliques

Régnier, M. (2018) · theses.fr (ABES) · doi:10.70675/2fb92711z373cz4b27z8082z7aa3f8930e63

Implications du microbiote intestinal et de la pectine dans la stéato-hépatite non-alcoolique

Houron, C. (2020) · theses.fr (ABES) · doi:10.70675/282e9d85z4f3dz4f5bz9045zd1ce6da72037

Current diabetes drugs: Lessons learned and implications for next-generation therapeutics

Liao, J., Cong, Z., Liu, K., Que, H., & Liu, F. (2026) · The Innovation Drug Discovery · doi:10.59717/j.xinn-drugdisc.2026.100008

DGAT2: A key therapeutic target in lipid synthesis regulation and metabolic diseases

Cheng, J.-Y., Gu, H.-X., He, C.-H., Gong, W., Yang, K.-J., Liu, Y.-Y., Chen, Z., Jiao, Q.-B., Zhang, X.-W., & Luo, H. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179145

Role of Protein Kinase C in Insulin Resistance and Metabolic Syndrome

Cruz-Villarreal, D. E., Hernández-González, K. D., & Olivares-Reyes, J. A. (2026) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases4030025

Liver-targeted DGAT2 siRNA ameliorates steatosis and fibrosis in a high-fat diet–induced MASH mouse model

Zhang, E., Zheng, W., LI, Y., Cheng, Z., Cai, Y., Cheng, Y., Zhang, X., Hou, Q., Liu, Y., Bingxue, M., et al. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2721709

BindingDB Entry 50007641: The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease.

BindingDB (2021) · UC San Diego · doi:10.7270/q2dj5jxg

BindingDB Entry 50046531: Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3.

BindingDB (2016) · UC San Diego · doi:10.7270/q2f191hj

BindingDB Entry 50006375: Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors.

BindingDB (2020) · UC San Diego · doi:10.7270/q28w3h9f

Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†

Yu, X. X., Murray, S. F., Pandey, S., Booten, S. L., Bao, D., Song, X., Kelly, S., Chen, S., McKay, R. A., Monia, B. P., et al. (2005) · Hepatology · doi:10.1002/hep.20783 · Cited by 305

Hepatocyte Deletion of Triglyceride‐Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice

Gluchowski, N. L., Gabriel, K. R., Chitraju, C., Bronson, R. T., Mejhert, N., Boland, S., Wang, K., Lai, Z. W., Farese, R. V., & Walther, T. C. (2019) · Hepatology · doi:10.1002/hep.30765 · Cited by 128

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

Yamaguchi, K., Yang, L., McCall, S. J., Huang, J., Yu, X. X., Pandey, S., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,067

266-OR: Plasma Membrane sn-1,2 Diacylglycerol Mediates Lipid-Induced Hepatic Insulin Resistance

Lyu, K., ZHANG, Y., Zhang, D., Kahn, M., Nozaki, Y., Bhanot, S., Bogan, J. S., Cline, G. W., Samuel, V. T., & Shulman, G. I. (2019) · Diabetes · doi:10.2337/db19-266-or

Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2

Savage, D. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27300 · Cited by 447